awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54977145-6A7C4B7C-C181-44B3-B885-AF2CE20F830F
Q54977145-6A7C4B7C-C181-44B3-B885-AF2CE20F830F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54977145-6A7C4B7C-C181-44B3-B885-AF2CE20F830F
Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.
P2860
Q54977145-6A7C4B7C-C181-44B3-B885-AF2CE20F830F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54977145-6A7C4B7C-C181-44B3-B885-AF2CE20F830F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9be9ed11629aa3722a22490fe4c98132dba0fa21
P2860
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group